|Awarded On||August 21, 2019|
|Title||Gulf Coast Consortium High-throughput Flow Cytometry Program (HtFCP)|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||Texas A&M University Health Science Center Institute of Biosciences and Technology|
|Principal Investigator/Program Director||Margarita Martinez-Moczygemba|
|Cancer Sites||All Sites|
*Pending contract negotiation
Flow cytometry is the method of choice for both immuno-oncology and leukemia / lymphoma research because it is ideally suited to studies with non-adherent cells and also studies that require co-cultures of tumor cells with cells that constitute their micro-environment. Until recently the power of flow cytometry as a tool for cancer research has been limited by the very low sample throughput of conventional flow cytometers. This problem has recently been solved by the development of automated flow cytometers that allow investigators to test the activity of thousands of drugs and drug combinations on cancer cells and immuno-therapeutics. Automated flow cytometry will have a transformative effe...